Table 3.
Financial analysis of the mass medication program for enterobiasis*
| Year, Enterobius vermicularis prevalence, estimated cases (No.)/1,000 residents | Cost of treatment = No. of cases treated × cost ($8) per resident, $ | Cost of contact screening = No. of contacts (3/case) × cost ($5) per screening test, $ | Total annual program cost for treatment and screening, $ |
|---|---|---|---|
| 1993, 29%, 290 | 2,320 | 4,350 | 6,670 |
| 1994, 21%, 210 | 1,680 | 3,150 | 4,830 |
| 1995†, 680 | 5,440 | 0 | 5,440 |
| 1998, 1%, 10‡ | 2,400 | 0 | 2,400 |
| Year, hypothetic; zero prevalence | 0 | 0 | 0 |
For assumptions, see the description of the financial analysis under “Participants and methods”
Gives the actual initial cost of mass treatment of all ambulatory residents.
Includes 290 contacts.